康思葆（北京）生物技术有限公司（简称“康思葆”）成立于2007年，是一家致力于细胞与基因治疗新技术开发与推广的高新技术企业。具体业务包括细胞药物研发、细胞存储、细胞技术转化应用、医美抗衰、健康管理等多个管线。此外，还销售NK细胞培养基和相关试剂，承担基因检测外包项目。
Founded in 2007, Cansbio (Beijing) Biotechnology Co., Ltd. (hereinafter referred to as "Cansbio") is a high-tech enterprise dedicated to the development and promotion of new cell and gene therapy technologies. The specific business includes multiple pipelines such as cell drug research and development, cell storage, cell technology transformation and application, medical beauty and anti-aging, and health management. In addition, it also sells NK cell culture media and related reagents, and undertakes genetic testing outsourcing projects.
在细胞药物研发领域，公司成立了免疫研究中心，建立符合GMP标准的免疫细胞医学研究试验室基地，专注于免疫细胞和干细胞的药物研究与开发。包含了针对恶性肿瘤、黑色素瘤、骨髓瘤、肝癌、结肠癌、多发性硬化症、红斑狼疮等多种疾病的临床研究，目前多个开发药物在进行IIT的研究申请。公司自主知识产权发明专利“蛋白-细胞偶联物、其制备方法和用途”已获得中国、美国、日本授权，以此平台研发的治疗性疫苗，对自身免疫性疾病、感染性疾病和恶性肿瘤疾病具有明确的治疗作用。
In the field of cell drug research and development, the company has established an immunological research center and established an immune cell medicine research laboratory base that meets GMP standards, focusing on the drug research and development of immune cells and stem cells. It contains clinical studies for malignant tumors, melanoma, myeloma, liver cancer, colon cancer, multiple sclerosis, lupus erythematosus and other diseases, and a number of developed drugs are currently under IIT research applications. The company's invention patent of independent intellectual property rights "protein-cell conjugates, their preparation methods and uses" has been authorized by China, the United States and Japan, and the therapeutic vaccines developed on this platform have clear therapeutic effects on autoimmune diseases, infectious diseases and malignant tumor diseases.
在细胞存储领域，康思葆专注于专注于打造自动化、智能化、数字化管理的细胞库，提供成人免疫细胞、脂肪干细胞、成纤维干细胞、造血干细胞、脐带间充质干细胞、胎盘间充质干细胞的存储服务，守护家庭健康。公司设立了临床医药级细胞库，通过了ISO 9001国际质量体系认证，确保细胞品质可控，满足各地民众细胞存储与制备需求。自主研发和制造了自动化、智能化深低温生物样本存储设备和运作管理体系，具备现代化、高质量控制、高效能和高安全性特性，可为客户提供细胞等生物样本超低温存储和管理全方位或个性化解决方案。2024年，康思葆“自体免疫细胞存储”服务获五星级认证，是国内首家获得第三方权威机构中诚信五星级认证的企业。
In the field of cell storage, Cansbio focuses on building an automated, intelligent and digitally managed cell bank, providing storage services for adult immune cells, adipose stem cells, fibroblast stem cells, hematopoietic stem cells, umbilical cord mesenchymal stem cells, and placental mesenchymal stem cells to protect family health. The company has set up a clinical pharmaceutical-grade cell bank, which has passed the ISO 9001 international quality system certification to ensure that the cell quality is controllable and meet the needs of people around the world for cell storage and preparation. It has independently developed and manufactured automated and intelligent cryogenic biological sample storage equipment and operation management system, which has modern, high-quality control, high efficiency and high security characteristics, and can provide customers with all-round or personalized solutions for ultra-low temperature storage and management of biological samples such as cells. In 2024, Bioslab's "Autologous Immune Cell Storage" service was awarded a five-star certification, making it the first company in China to receive a five-star certification from a third-party authority.
在细胞应用服务领域，康思葆专注于NK细胞、脐带间充质干细胞、自体脂肪干细胞、外泌体等新产品新技术的研发服务。公司率先引进并独家代理日本小田医院NK细胞过继免疫疗法，该疗法作为一种新型的癌症治疗手段，在国际上获得广泛认可。同时，公司与美国NIH、罗格斯大学、耶鲁大学等团队展开合作，及时有效的转化国际上细胞领域的相关先进技术。
In the field of cell application services, Cansbio focuses on the R&D services of new products and technologies such as NK cells, umbilical cord mesenchymal stem cells, autologous adipose stem cells, and exosomes. The company took the lead in introducing and exclusively acting as an agent for NK cell adoptive immunotherapy at Oda Hospital in Japan, which has been widely recognized internationally as a new type of cancer treatment. At the same time, the company cooperates with teams such as NIH, Rutgers University, Yale University and other teams to timely and effectively transform relevant advanced technologies in the field of cells in the world.
在医美抗衰领域，康思葆致力于将细胞生物学科研成果转化为护肤方案，探索改善肌肤的无限可能。旗下“润妍泌语”品牌遵循细胞成长规律，将再生医学研究与技术成果转化应用于医学美容抗衰领域，专研高端细胞生物护肤产品，推动以细胞外小囊泡为核心的再生医学美容抗衰新方案。同时自体成纤维细胞项目根据不同客户的皮肤类型和需求，量身定制最合适的抗衰方案。
In the field of medical aesthetics and anti-aging, Cansbio-Cover is committed to translating the scientific research results of cell biology into skincare solutions, exploring the infinite possibilities of improving skin. Its "RYM" brand follows the law of cell growth, applies regenerative medicine research and technological achievements to the field of medical cosmetology and anti-aging, specializes in high-end cell biological skin care products, and promotes a new regenerative medicine cosmetic and anti-aging program with extracellular small vesicles as the core. At the same time, the autologous fibroblast program tailors the most suitable anti-aging program according to the skin type and needs of different customers.
在健康管理领域，为了协助会员更好地进行健康管理，康思葆健康管理中心推出了会员制家庭健康管家服务产品，旨在为家庭会员提供从预防到诊疗，从健康管理到医养结合的全生命周期健康管家式服务。
In the field of health management, in order to assist members in better health management, HealthBreath Health Management Center has launched a membership-based family health butler service product, aiming to provide family members with a full life cycle health butler service from prevention to diagnosis and treatment, from health management to medical care and elderly care.
星河浩瀚，人类对于科学的探索永无终点，我们对健康的守护也将代代绵延。作为一家细胞领域的企业，康思葆的长期愿景是成为百年企业，成就百岁人生。
The galaxy is vast, and human exploration of science will never end, and our protection of health will continue from generation to generation. As a company in the cell field, Cansbio's long-term vision is to become a 100-year-old company and achieve a 100-year-old life.